(Q70555092)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430681%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

title

A controlled, double-blind, randomized trial of verapamil and cyclosporine in cadaver renal transplant patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430681%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430681%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

Alan I Reed

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430681%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

6

H W Sollinger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430681%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

author name string

J D Pirsch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430681%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

A M D'Alessandro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430681%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

E B Roecker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430681%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

M Kalayoglu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430681%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

F O Belzer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430681%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

publication date

1 February 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430681%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

12 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430681%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430681%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430681%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

page(s)

189-195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430681%20AND%20SRC:MED&resulttype=core&format=json

A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years

12 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Cyclosporine-associated chronic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Renal histopathologic alterations in patients treated with cyclosporine for uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Cyclosporine nephrotoxicity: pathogenesis, prophylaxis, therapy, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Verapamil inhibition of lymphocyte proliferation and function in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

The effect of verapamil on cellular uptake, organ distribution, and pharmacology of cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Do Calcium Channel Blockers Have Any Influence on the Immunological Status of Renal Graft Recipients on Ciclosporin Therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Effects of calcium channel blockers on in vivo cellular immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Protection against cyclosporine-induced impairment of renal microcirculation by verapamil in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics, and urine prostaglandin production of healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Cyclosporin-diltiazem interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Influence of diltiazem on cyclosporin clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Cyclosporin-verapamil interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

The effect of calcium channel blockers on the cyclosporine dose requirement in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Pharmacokinetic interaction between cyclosporin and diltiazem

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Calcium channel antagonists and cyclosporine metabolism: in vitro studies with human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Effects of calcium channel blockers on renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Cyclosporine-induced changes in glomerular filtration rate and urea excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

The long-term course of cyclosporine-associated chronic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

The impairment of true glomerular filtration rate in long-term cyclosporine-treated pediatric allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Additive inhibition of afferent and efferent immunological responses of human peripheral blood mononuclear cells by verapamil and cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Does nifedipine ameliorate cyclosporin A nephrotoxicity?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Prevention of posttransplant acute tubular necrosis by the calcium antagonist diltiazem: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

The clinical significance of cyclosporine metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Cyclosporine-induced renal dysfunction in human renal allograft recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Cyclosporine-associated hypertension in cardiopulmonary transplantation. The beneficial effect of nifedipine on renal function.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981092-4

7 January 2021

10.1016/S0272-6386(12)81092-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430681%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference